ILXQuant Biodefense and Pandemic Preparedness Basket Index
Fixed-basket index of 10 companies providing the infrastructure of biological security -- next-generation vaccine platforms (Novavax protein subunit, Vaxart oral), US strategic national stockpile vaccines (Emergent BioSolutions), biodefense antivirals (SIGA Technologies -- the only FDA-approved smallpox antiviral), molecular diagnostics (Qiagen), immune surveillance sequencing (Adaptive Biotechnologies), food and environmental biosurveillance (Neogen), veterinary outbreak detection (Heska -- critical for H5N1 zoonotic monitoring), synthetic biology for biodefense (Precigen), and drug delivery innovation (Nektar). Government biodefense contracts provide recession-proof revenue streams. Rebalances quarterly to equal weight.
- Index identifier
- ILXBIO
- Category
- Basket
- Universe
- Fixed basket -- 10 biodefense and pandemic preparedness companies (equal weight)
- Currency
- USD
- Inception
- 2020-03-02
- Rebalancing
- Quarterly (first Monday of March, June, September, December)
- Index fee
- 0.60% p.a.
- Reference benchmark
- iShares Aero and Defense (ITA)
Performance and risk
All figures below are measured over a trailing window of up to 1,260 trading days (approximately five years), not since index inception.
| Annualised return | -7.30% |
|---|---|
| Sharpe ratio | -0.17 |
| Calmar ratio | -0.09 |
| Volatility | 42.68% |
| Maximum drawdown | -78.05% |
| Return, 1 month | +5.10% |
| Return, 3 months | +7.63% |
| Return, 1 year | +43.81% |
| Return, year to date | +10.84% |
Full performance history, drawdown analysis, rolling risk metrics and portfolio breakdowns for this index are available in the ILX Quant platform.